⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 34 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 34 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT September 14, 2026

Dermovate - Creme (Creme)

📷 Wikipedia: Clobetasol propionate · Source
Dermovate - Creme (Creme)
📷 Wikipedia: Clobetasol propionate · Source

🚫 Parallel export ban active

ATC
D07AD01
Reason
Erhöhter Mehrbedarf
Marketing authorisation holder
Glaxosmithkline Pharma GmbH, Wienerbergstraße 7, 1100 Wien, Österreich
Affected packs
1 Stück Schachtel, Tube [Nicht verfügbar, since 2026-09-14, resupply 2026-10-10]

1 Stück Schachtel, Tube [Nicht verfügbar, since 2026-09-14, resupply 2026-10-10]

⚠️
Shortage ongoing
CLOBETASOL PROPIONAT is currently in short supply in AT.
📈 Timeline
1 days active so far
September 15, 2026 September 15, 2026
Daily snapshot data starts accumulating once the scheduler runs — for now this is interpolated from the agency's first/last dates.
A plain-language summary will appear here shortly. Read the official notice below.
🔬 Medical / technical details (for professionals)
Active substance(s)
CLOBETASOL PROPIONAT
Agency-published detail

🚫 Parallel export ban active · ATC: D07AD01 · Reason: Erhöhter Mehrbedarf · Marketing authorisation holder: Glaxosmithkline Pharma GmbH, Wienerbergstraße 7, 1100 Wien, Österreich · Affected packs: 1 Stück Schachtel, Tube [Nicht verfügbar, since 2026-09-14, resupply 2026-10-10] · 1 Stück Schachtel, Tube [Nicht verfügbar, since 2026-09-14, resupply 2026-10-10]

First published
September 14, 2026
Last refreshed by us
10 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

High AT 1 day ago

Dermovate - Salbe (Salbe)

Parallel export of Dermovate ointment is banned.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Dermovate - Creme (Creme). 🚫 Parallel export ban active · ATC: D07AD01 · Reason: Erhöhter Mehrbedarf · Marketing authorisation holder: Glaxosmithkline Pharma GmbH, Wienerbergstraße 7, 1100 Wien, Österreich · Affected packs: 1 Stück Schachtel, Tube [Nicht verfügbar, since 2026-09-14, resupply 2026-10-10] ·...
▸ When was this alert issued?
This alert was issued on September 14, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.